Armata Pharmaceuticals ARMP
NYSE ARMP
$3.08 -0.12 (-3.75%)
As of: Oct 21, 2026 · 3:59 PM EDT

Armata Pharmaceuticals (ARMP) Current Debt (2023)

Updated

Armata Pharmaceuticals (ARMP) reported Current Debt of -$815,000 for FY2017, compared with -$100,000 in FY2016.

Analysis

Armata Pharmaceuticals (ARMP) Current Debt (2023) Analysis & Trends

  • According to Business Quant data, Current Debt came in at -$100,000 in FY2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Debt (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 3.51 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -5.75 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 208.00 Mn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 64.00 Mn
10 Armata Pharmaceuticals 110.98 Mn 58.69 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 -368,000.00
Mar 31, 2023 29.59 Mn
API Access

Armata Pharmaceuticals Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-debt&ticker=ARMP&period=max&api_key=YOUR_API_KEY